Related Experiment Video
Updated: Nov 11, 2025

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Chronic renal dysfunction in cirrhosis: A new frontier in hepatology
Ramesh Kumar1, Rajeev Nayan Priyadarshi2, Utpal Anand3
1Department of Gastroenterology, All India Institute of Medical Sciences, Patna 801507, Bihar, India. docrameshkr@gmail.com.
Insights
Chronic kidney disease (CKD) is increasingly diagnosed in liver cirrhosis patients due to risk factors like diabetes and hypertension. Differentiating CKD from acute kidney injury (AKI) is crucial for managing these complex hepatorenal cases.
Area of Science:
- Hepatology and Nephrology
- Gastroenterology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) diagnosis is rising in liver cirrhosis patients.
- Risk factors like diabetes, hypertension, and NAFLD contribute to CKD prevalence.
- Newer CKD definitions aid differentiation from acute kidney injury (AKI).
Discussion:
- CKD in cirrhosis can be structural or functional, stemming from kidney injury or circulatory imbalances.
- Limited literature exists on combined cirrhosis-CKD, with focus often on AKI.
- Challenges include GFR estimation, lack of biomarkers, and biopsy difficulties.
Key Insights:
- AKI can progress to CKD in decompensated cirrhosis.
- Combined hepatorenal dysfunction complicates fluid management and drug tolerance.
- Clinical decision-making for transplantation (liver vs. liver-kidney) is challenging.
Outlook:
- This review provides an overview of CKD in cirrhosis.
- It highlights clinical consequences and diagnostic/treatment challenges.
- Further research is needed to address knowledge gaps in combined hepatorenal disorders.
Abstract:
Chronic kidney disease (CKD) in patients with liver cirrhosis has become a new frontier in hepatology. In recent years, a sharp increase in the diagnosis of CKD has been observed among patients with cirrhosis. The rising prevalence of risk factors, such as diabetes, hypertension and nonalcoholic fatty liver disease, appears to have contributed significantly to the high prevalence of CKD. Moreover, the diagnosis of CKD in cirrhosis is now based on a reduction in the estimated glomerular filtration rate of < 60 mL/min over more than 3 mo. This definition has resulted in a better differentiation of CKD from acute kidney injury (AKI), leading to its greater recognition. It has also been noted that a significant proportion of AKI transforms into CKD in patients with decompensated cirrhosis. CKD in cirrhosis can be structural CKD due to kidney injury or functional CKD secondary to circulatory and neurohormonal imbalances. The available literature on combined cirrhosis-CKD is extremely limited, as most attempts to assess renal dysfunction in cirrhosis have so far concentrated on AKI. Due to problems related to glomerular filtration rate estimation in cirrhosis, the absence of reliable biomarkers of CKD and technical difficulties in performing renal biopsy in advanced cirrhosis, CKD in cirrhosis can present many challenges for clinicians. With combined hepatorenal dysfunctions, fluid mobilization becomes problematic, and there may be difficulties with drug tolerance, hemodialysis and decision-making regarding the need for liver vs simultaneous liver and kidney transplantation. This paper offers a thorough overview of the increasingly known CKD in patients with cirrhosis, with clinical consequences and difficulties occurring in the diagnosis and treatment of such patients.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease II: Clinical Manifestations

